Unknown PHASE1 INTERVENTIONAL 1-arm NCT06045286

High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM (HaRyPOT)

High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for Microsatellite Stable (MSS) Colorectal Liver Metastases (CRLM)

Sponsor: Jiangsu Cancer Institute & Hospital

Conditions Colorectal Liver Metastases

Interventions PD-1 Inhibitors Radiation: High- and Low-dose radiotherapy

Updated 4 times since 2023 Last updated: Sep 13, 2023 Started: Sep 20, 2023 Primary completion: Sep 30, 2024 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Colorectal Liver Metastases, this trial is ongoing. The trial is conducted by Jiangsu Cancer Institute & Hospital and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Unknown PHASE1

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Oct 2023 — Jul 2024 [monthly]

Recruiting PHASE1

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu Cancer Institute & Hospital

Data source: Jiangsu Cancer Institute & Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China